|
|
Volumn 20, Issue 2, 2007, Pages 139-144
|
|
Therapeutic approaches towards the treatment of gastroinstestinal disorders
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ALEMCINAL;
ALOSETRON;
ANTIDEPRESSANT AGENT;
AZD 0865;
CERTOLIZUMAB PEGOL;
CIMETIDINE;
CISAPRIDE;
ERYTHROMYCIN;
ESOMEPRAZOLE;
ETANERCEPT;
INFLIXIMAB;
LOPERAMIDE;
METOCLOPRAMIDE;
MITEMCINAL;
MLN 0002;
MONOCLONAL ANTIBODY;
OMEPRAZOLE;
PICOPRAZOLE;
PLACEBO;
PROBIOTIC AGENT;
PROTON PUMP INHIBITOR;
RANITIDINE;
SPASMOLYTIC AGENT;
TEGASEROD;
TIMOPRAZOLE;
TROPISETRON;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
UNCLASSIFIED DRUG;
GASTROINTESTINAL AGENT;
GASTROINTESTINAL HORMONE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CROHN DISEASE;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG STRUCTURE;
ENTERITIS;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL DISEASE;
GASTROINTESTINAL MOTILITY;
HUMAN;
IRRITABLE COLON;
NONHUMAN;
STOMACH ACID SECRETION;
STOMACH PARESIS;
ULCERATIVE COLITIS;
ANIMAL;
DRUG DESIGN;
DRUG EFFECTS;
GASTROENTEROLOGY;
GASTROINTESTINAL DISEASES;
GASTROINTESTINAL TRACT;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
PATHOPHYSIOLOGY;
SIGNAL TRANSDUCTION;
ANIMALS;
DRUG DESIGN;
GASTROENTEROLOGY;
GASTROINTESTINAL AGENTS;
GASTROINTESTINAL DISEASES;
GASTROINTESTINAL HORMONES;
GASTROINTESTINAL MOTILITY;
GASTROINTESTINAL TRACT;
HUMANS;
MOLECULAR TARGETED THERAPY;
SIGNAL TRANSDUCTION;
|
|
EID: 34250317047
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: 10.1358/dnp.2007.20.2.1113595 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|